APD nucleoside derivative (RFS Pharma)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameAPD nucleoside derivative (RFS Pharma)

Drug Alias Name(-)-beta-D-2-aminopurine dioxolaneDXG prodrug (RFS Pharma)(-)-beta-D-dioxolane guaninenucleoside reverse transcriptase inhibitor (RFS Pharma)DXG

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionNucleotide reverse transcriptase inhibitors

TargetsNucleotide reverse transcriptase

Therapy Area/IndicationsHepatitis BHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesRfs Pharma Llc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesRfs Pharma Llc

Active IndicationsN/A

Inactive IndicationsHepatitis BHIV Infections

Other Information

ATC CodeN/A